Signalling from dead cells drives inflammation and vessel remodelling

被引:22
作者
Bennett, Martin [1 ]
Yu, Haixiang [1 ]
Clarke, Murray [1 ]
机构
[1] Univ Cambridge, Addenbrookes Hosp, Div Cardiovasc Med, Addenbrookes Ctr Clin Invest, Cambridge CB2 0QQ, England
关键词
Apoptosis; Atherosclerosis; Remodelling; Necrosis; SMOOTH-MUSCLE-CELLS; NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR-I; APOPTOTIC CELLS; ATHEROSCLEROTIC PLAQUE; NEOINTIMAL HYPERPLASIA; ENDOTHELIAL-CELLS; INDUCE APOPTOSIS; DEFICIENCY LEADS; NITRIC-OXIDE;
D O I
10.1016/j.vph.2012.01.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Death of vascular smooth muscle cells (VSMCs) has been demonstrated in vessel development and in disease, most notably in atherosclerosis, but also after injury and remodelling. VSMC death promotes multiple features of vulnerable plaques, but also induces features of normal vessel ageing and cystic medial necrosis, including loss of VSMCs, elastin fragmentation and loss, increased glycosaminoglycans and speckled calcification. VSMC apoptosis in the absence of efficient phagocytosis also produces inflammation due to secondary necrosis; in contrast, VSMC apoptosis in normal vessels can be silent. We have investigated the consequences of VSMC apoptosis in both disease and during vessel remodelling. We find that VSMCs release specific cytokines dependent upon the mode of cell death; IL-1 beta predominates during apoptosis, whilst IL-1 alpha predominates during necrosis. Both IL-1 alpha and beta promote release of further cytokines from adjacent live cells, in particular IL-6 and MCP-1. The balance of cytokines results in pathology with differing compositions, including inflammation or neointima formation/vascular repair, via direct promotion of VSMC proliferation and migration. Thus, VSMC death can promote either pathology or repair, depending upon the context and cytokine signalling. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:187 / 192
页数:6
相关论文
共 85 条
[1]   Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia [J].
Abid, MR ;
Yano, K ;
Guo, SD ;
Patel, VI ;
Shrikhande, G ;
Spokes, KC ;
Ferran, C ;
Aird, WC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (33) :29864-29873
[2]   Defective Mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis [J].
Ait-Oufella, Hafid ;
Pouresmail, Vahid ;
Simon, Tabassome ;
Blanc-Brude, Olivier ;
Kinugawa, Kiyoka ;
Merval, Regine ;
Offenstadt, Georges ;
Leseche, Guy ;
Cohen, Philip L. ;
Tedgui, Alain ;
Mallat, Ziad .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (08) :1429-1431
[3]   Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice [J].
Ait-Oufella, Hafid ;
Kinugawa, Kiyoka ;
Zoll, Joffrey ;
Simon, Tabassome ;
Boddaert, Jacques ;
Heeneman, Silvia ;
Blanc-Brude, Olivier ;
Barateau, Veronique ;
Potteaux, Stephane ;
Merval, Regine ;
Esposito, Bruno ;
Teissier, Elisabeth ;
Daemen, Mat J. ;
Leseche, Guy ;
Boulanger, Chantal ;
Tedgui, Alain ;
Mallat, Ziad .
CIRCULATION, 2007, 115 (16) :2168-2177
[4]   Akt regulates the survival of vascular smooth muscle cells via inhibition of FoxO3a and GSK3 [J].
Allard, David ;
Figg, Nichola ;
Bennett, Martin R. ;
Littlewood, Trevor D. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (28) :19739-19747
[5]   Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease [J].
Aprahamian, T ;
Rifkin, I ;
Bonegio, A ;
Hugel, B ;
Freyssinet, JM ;
Sato, K ;
Castellot, JJ ;
Walsh, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (08) :1121-1131
[6]  
Ares MPS, 1997, J LIPID RES, V38, P2049
[7]   Regulation of vascular smooth muscle cell apoptosis - Modulation of bad by a phosphatidylinositol 3-kinase-dependent pathway [J].
Bai, HZ ;
Pollman, MJ ;
Inishi, Y ;
Gibbons, GH .
CIRCULATION RESEARCH, 1999, 85 (03) :229-237
[8]   Role of smooth muscle cell death in advanced coronary primary lesions:: implications for plaque instability [J].
Bauriedel, G ;
Hutter, R ;
Welsch, U ;
Bach, R ;
Sievert, H ;
Lüderitz, B .
CARDIOVASCULAR RESEARCH, 1999, 41 (02) :480-488
[9]   Fas ligand/Fas-mediated apoptosis in human coronary artery smooth muscle cells: therapeutic implications of fratricidal mode of action [J].
Belanger, AJ ;
Scaria, A ;
Lu, HW ;
Sullivan, JA ;
Cheng, SH ;
Gregory, RJ ;
Jiang, CW .
CARDIOVASCULAR RESEARCH, 2001, 51 (04) :749-761
[10]   Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis [J].
Bennett, M ;
Macdonald, K ;
Chan, SW ;
Luzio, JP ;
Simari, R ;
Weissberg, P .
SCIENCE, 1998, 282 (5387) :290-293